Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2Plasma cell 1Myeloid 1Lymphoid 1

Conditions

Leukemia 15Hematologic Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Neoplasms 5Myelodysplastic Syndromes 5Leukemia, Lymphocytic, Chronic, B-Cell 5Lymphoma 4Leukemia, Myeloid, Acute 4Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Hodgkin Disease 3Fatigue 3Uterine Cervical Neoplasms 2Splenomegaly 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Breast Neoplasms 2Anemia 2Weight Loss 1Vaginal Neoplasms 1Uterine Neoplasms 1Thyroid Neoplasms 1Thrombocytopenia 1Sleep Initiation and Maintenance Disorders 1Sarcoma 1Pyloric Stenosis, Hypertrophic 1Prostatic Neoplasms 1Primary Myelofibrosis 1Patient Participation 1Ovarian Cysts 1Osteonecrosis 1

Interventions

Epoetin Alfa 11Lenalidomide 5fludarabine phosphate 4Cyclosporine 4Cyclophosphamide 4fludarabine 3Filgrastim 3Darbepoetin alfa 3Busulfan 3Antilymphocyte Serum 3thymoglobulin 2Thiotepa 2Therapeutics 2Surveys and Questionnaires 2Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Ferric Oxide, Saccharated 2Biopsy 2AP 1903 reagent 2venetoclax 1trametinib 1ruxolitinib 1regorafenib 1ponatinib 1pertuzumab 1pembrolizumab 1palbociclib 1olaparib 1obinutuzumab 1neratinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anemia × Surveys and Questionnaires × Other hematologic neoplasm × Clear all
NCT02948283 2021-02-12

Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

City of Hope Medical Center

Phase 1 Completed
3 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Lymphadenopathy, Anemia, Fatigue, Fever, Lymphocytosis, Multiple Myeloma, Splenomegaly, Thrombocytopenia, Weight Loss, Leukemia, Lymphocytic, Chronic, B-Cell

NCT02730884 2020-08-07

Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 6 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Splenomegaly, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡